En los medios

18 Oct 2017 - LaCerca.com

LaCerca.com has echoed on the 25 centres—among them IRB Barcelona—and the 16 research units accredited with the distinctions of excellence " Severo Ochoa" and " María de Maeztu", respectively, which have set up the Severo Ochoa and María de Maeztu Alliance. Among other objectives, this alliance seeks to promote the exchange of knowledge, technology and good practices and have a voice in Spanish and European scientific politics.

Link to LaCerca.com

17 Oct 2017 - Canal Diabetes

Several media, including Canal Diabetes, has dedicated an article to the first joint meeting of the French, Portuguese and Spanish Biochemistry and Molecular Biology Societies (FEBS3+), which will take place in the Palau de Congressos of the Fira de Barcelona from 23 to 26 October. Gathering top scientists, the meeting will be presided by Antonio Zorzano, group leader at IRB Barcelona and coordinator of the Molecular Medicine Programme, as well as professor at the University of Barcelona and CIBER for Diabetes and Associated Metabolic Diseases.

Link to Canal Diabetes

Link to ...

<p>Group leader Salvador Aznar Benitah and first author Gloria Pascual in the Stem Cells and Cancer lab at the IRB Barcelona (M. Minocri, IRB Barcelona)</p>
15 Oct 2017 - Onda Cero

The radio programme Te doy mi palabra broadcasted by Onda Cero has referred to a study by ICREA researcher Salvador Aznar Benitah. Published in Nature in December 2016, the research revealed that consuming certain fats stimulates metastasis. Aznar Benitah’s team reached this conclusion after examining the effect of dietary fatty acid intake in mice.

Link to Te doy mi palabra (Onda Cero)

<p>Joan J. Guinovart, founder of IRB Barcelona</p>
14 Oct 2017 - La Nueva España

The website La Nueva España has echoed the participation of Joan Guinovart, director and researcher at IRB Barcelona, in Science Week in Valdés, Asturias. Guinovart will kick off the event with a talk about diabetes. Science Week will be held from 10 to 15 November.

Link to La Nueva España

<p>In August, IRB Barcelona scientists published two studies devoted to circadian rhythm, aging and diet in the journal Cell.</p>
5 Oct 2017 - El Mundo and Correio de Mahnà

The prize is shared between American scientists Jeffrey C Hall, Michael Rosbash and Michael W Young for work on the internal clock of living organisms, using the fruit flies for their research.

Their discoveries explain how plants, animals and humans adapt their biological rhythm to synchronise with the rotation of the Earth.

The biological clock helps to regulate sleep patterns, feeding behaviour, hormone release and blood pressure.

Salvador Aznar Benitah, scientist at IRB Barcelona studying the day-night cycle in adult stem...

3 Oct 2017 - El Mundo - Innovadores

The technology supplement Innovadores of the newspaper El Mundo has echoed on the award of 220,000 euros to three biomedical innovation projects underway at IRB Barcelona. This funding has been given by the Agency for Management and University and Research Grants (AGAUR, acronym in Catalan) of the Catalan Government, with the support of ERDFs.

<p>Salvador Aznar Benitah leads the Stem Cells and Cancer laboratory at IRB Barcelona</p>
1 Oct 2017 - Cuerpo Mente

The magazine Cuerpo Mente has highlighted the study published in Nature in December 2016 by the group headed by ICREA researcher Salvador Aznar Benitah. He and his team analysed the impact of fatty acid intake on metastasis in mice. The results revealed that there is a relationship between diet and the metastatic potential of tumours.

<p>Teresa Tarragó is co-founder of IProteos, an IRB Barcelona spinf-off (D. Portales)</p>
25 Sep 2017 - Innovaspain.com

Innovaspain.com has dedicated an article to the research undertaken by Iproteos, a company specialized in the discovery of drugs for diseases of the nervous system. This spin-off company of IRB Barcelona has demonstrated the effectiveness of a novel compound, IPR-19, to reverse the cognitive deficit associated with schizophrenia in mouse models. At present, this peptide is in the preclinical phase.

Link to Innovaspain.com

<p>Teresa Tarragó, CEO and co-founder of Iproteos</p>
23 Sep 2017 - Agencia SINC

Agencia SINC echoes the interest of pharmaceutical multinationals in Iproteos. Founded in 2011 by Teresa Tarragó, this biotechnology company is a spin-off of IRB Barcelona. Since then, Tarragó aimed to convert a molecule (IPR-19) discovered during her research into a drug. This molecule has great potential for the treatment of cognitive problems caused by schizophrenia.

Link to Agencia SINC

19 Sep 2017 - Biocat News

Biocat news channel interviews Oscar Flores, co-founder and CEO of Made of Genes. An IRB Barcelona alumnus, Oscar did his PhD in Biomedicine at IRB Barcelona and the Barcelona Supercomputing Center (BSC).

Made of Genes focuses on transactional genomics, helping individuals and companies obtain, store, move, manage and analyse genetic and biomedical data safely and in compliance with legal regulations. Their goal: “For everyone to have their gene sequence in their back pocket and be able to use it every time they go to the doctor,” sums up Oscar Flores.

In the interview, Oscar Flores ...